The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index; none of the 331 sources its claims cite is checked for support yet.
Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches
Open accessAbstract
Pseudomonas aeruginosa (P. aeruginosa) forms biofilms that are difficult to eliminate. The matrix protects the cells, efflux pumps reduce intracellular drug levels, and dormant subpopulations survive treatment. Routine minimum inhibitory concentration (MIC) testing does not account for these features, which helps explain why infections often continue even when therapy appears appropriate. This review describes how quorum-sensing (QS) and cyclic di-guanosine monophosphate (c-di-GMP) regulate matrix production, efflux activity, and dormancy within P. aeruginosa biofilms. Important matrix components, including Psl, Pel, alginate, and extracellular DNA, slow the movement of antimicrobial agents. Regulatory proteins such as sagS and brlR increase the activity of the MexAB-OprM and MexEF-OprN efflux systems, further reducing intracellular drug concentrations. Oxygen and nutrient limitation promote persister cells and viable but nonculturable cells, with both having the ability to survive antibiotic levels that would normally be lethal. These defenses explain the gap between MIC values and biofilm-specific measurements, such as the minimum biofilm inhibitory concentration and the minimum biofilm eradication concentration. This review also summarizes emerging antibiofilm strategies. These include QS inhibitors, compounds that lower c-di-GMP, such as nitric oxide donors, nanoparticles, depolymerases, bacteriophages, and therapies that are directed at host targets. Modern diagnostic tools, such as confocal laser scanning microscopy, optical coherence tomography, and Raman spectroscopy, improve detection and guide treatment planning. A staged therapeutic approach is presented that begins with the dispersal or loosening of the matrix, continues with targeted antibiotics, and concludes with support for immune clearance. Viewing these strategies within a One Health framework highlights the role of biofilms in clinical disease and in environmental reservoirs and supports more effective surveillance and prevention.
Overview
CoChat Summary
TL;DR
This review describes how quorum sensing (QS) and c-di-GMP signaling coordinate *Pseudomonas aeruginosa* biofilm matrix production, efflux, dormancy, and antimicrobial tolerance, explaining why MIC testing often fails to predict biofilm treatment outcomes. It then surveys emerging antibiofilm strategies—QS inhibitors, c-di-GMP modulators, nanoparticles, phages/depolymerases, and host-directed therapies—and argues for biofilm-aware diagnostics and a One Health approach.
Key findings
- *P. aeruginosa* biofilms resist treatment through matrix components (Psl, Pel, alginate, eDNA), efflux pumps such as MexAB-OprM and MexEF-OprN, and dormant persister/VBNC subpopulations; MBIC and MBEC values often exceed planktonic MIC values by large margins.
- The PAO1 genome is about 6.3 megabases, and c-di-GMP turnover involves approximately 41 proteins: about 17 GGDEF-only, 5 EAL-only, and 16 dual GGDEF–EAL proteins, with additional HD-GYP proteins annotated.
- A thermosensory diguanylate cyclase increases its catalytic rate more than one hundred-fold across a ten-degree temperature change, linking environmental cues to biofilm lifestyle.
- A MALDI-TOF feature of approximately 5.45 kilodaltons corresponding to PA2146 increases during *P. aeruginosa* biofilm growth on biopsy channel polymers and is proposed as a biofilm-stage marker.
Methods
- Design: narrative review; no primary experiments, systematic search protocol, or meta-analysis are reported.
- Data/sample: synthesis of published literature on *P. aeruginosa* biofilms, QS, c-di-GMP signaling, antimicrobial tolerance, antibiofilm therapies, diagnostics, and One Health, with references numbered 1–302.
- Main analysis: thematic synthesis organized around biofilm architecture, QS and c-di-GMP regulatory networks, tolerance/persistence mechanisms, emerging therapeutic strategies, diagnostic tools, and translational barriers.
Limitations
- The paper states that resistance can emerge to QS inhibitors and phage-based therapies, that there is currently no general biofilm producer database across ESKAPE pathogens, and that ISO 10993-5 cytotoxicity results show substantial interlaboratory variability.
- Evident from the text: as a narrative review, it does not report systematic inclusion/exclusion criteria, search strategy, or risk-of-bias assessment, and it presents no primary experimental data.
- Evident from the text: many therapeutic and diagnostic claims are based on cited preclinical or in vitro studies, with limited clinical validation described for several approaches.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 153 Not checked · 19 Own results and interpretations
In the paper
“Biofilms represent a dynamic bacterial lifestyle rather than a fixed state.”
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > 1. Introduction
What the sources say
- Not checked yetcites [1] Flemming, 2016, Biofilms: An emergent form of bacterial life, Nat. Rev. Microbiol. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Mucoid conversion and increased alginate production alter the matrix and strengthen the chronic state of infection [3,4].”
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > 1. Introduction
What the sources say
- Not checked yetcites [3] Maurice, 2018, Pseudomonas aeruginosa biofilms: Host response and clinical implications in lung infections, Am. J. Respir. Cell Mol. Biol. source
- Not checked yetcites [4] Hentzer, 2001, Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function, J. Bacteriol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Other subpopulations can enter a VBNC state in response to disinfectants or antibiotic stress, as demonstrated in chlorine-exposed and catheter-associated biofilms [54,55,56].”
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > 2. Architectural and Molecular Foundations of P. aeruginosa Biofilms > 2.3. Spatial and Metabolic Heterogeneity: Oxygen and Nutrient Gradients, Persisters, and VBNC Cells
What the sources say
- Not checked yetcites [54] Qi, 2022, Metabolism differences of biofilm and planktonic Pseudomonas aeruginosa in viable but nonculturable state induced by chlorine stress, Sci. Total Environ. source
- Not checked yetcites [55] Wilks, 2021, Biofilm development on urinary catheters promotes the appearance of viable but nonculturable bacteria, MBio source
- Not checked yetcites [56] Qi, 2024, Temporal metabolic dynamics and heterogeneity of viable but nonculturable Pseudomonas aeruginosa induced by chlorine disinfection at single-cell resolution, J. Environ. Chem. Eng. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“A hierarchical quorum-sensing (QS) network that includes the Las, Rhl, and Pseudomonas quinolone signal (PQS) systems, with added inputs such as the integrated QS signal, is central to the resilience of P. aeruginosa biofilms [16,17].”
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > 1. Introduction
What the sources say
- Not checked yetcites [16] Lee, 2015, The hierarchy quorum sensing network in Pseudomonas aeruginosa, Protein Cell source
- Not checked yetcites [17] Zhang, X., Li, S., Zhang, D., Zheng, S., Zhou, D., Hou, Q., Li, G., and Han, H. (2025). A comprehensive review of the pathogenic mechanisms of Pseudomonas aeruginosa: Synergistic effects of virulence factors, quorum sensing, and biofilm formation. Front. Microbiol., 16. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Dispersal is an actively controlled process that requires BdlA, a chemotaxis-like regulator whose phosphorylation state integrates environmental cues with c-di-GMP signaling [28,29,30,31].”
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > 2. Architectural and Molecular Foundations of P. aeruginosa Biofilms > 2.1. Staged Development: Attachment, Maturation, and Dispersal (pel, psl, algD, sadB, and bdlA)
What the sources say
- Not checked yetcites [28] Ryder, 2007, Role of polysaccharides in Pseudomonas aeruginosa biofilm development, Curr. Opin. Microbiol. source
- Not checked yetcites [29] Allison, 2024, The role of exopolysaccharides Psl and Pel in resistance of Pseudomonas aeruginosa to the oxidative stressors sodium hypochlorite and hydrogen peroxide, Microbiol. Spectr.
- Not checked yetcites [30] Colvin, 2012, The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix, Environ. Microbiol. source
- Not checked yetcites [31] Wozniak, 2003, Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms, Proc. Natl. Acad. Sci. USA source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
67 more claims
Create a free account to see all 172 claims and to verify the 331 references still open.
- It may state two separate claims as one. 85
- Probably not a substantial claim. 20
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > References
“19. Kuchma S. Ballok A. Merritt J. Hammond J. Lu W. Rabinowitz J.D. O’Toole G.A. Cyclic di-GMP-mediated repression of swarming motility by Pseudomonas aeruginosa PA14 requires the MotAB stator J. Bacteriol. 2010 197 420 430”
§ Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches > References
“34. Petrova O.E. Cherny K.E. Sauer K. The diguanylate cyclase GcbA facilitates Pseudomonas aeruginosa biofilm dispersion by activating BdlA J. Bacteriol. 2015 197 174 187”
Citations
Cites
Items 201–296 of 296
Do, H., Kwon, S.-R., Fu, K., Morales-Soto, N., Shrout, J. D., & Bohn, P. W. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b00184 · Cited by 44
Wilks, S. A., Koerfer, V. V., Prieto, J. A., Fader, M., & Keevil, C. W. (2021) · mBio · doi:10.1128/mbio.03584-20 · Cited by 44
Reichhardt, C. (2023) · Journal of Bacteriology · doi:10.1128/jb.00019-23 · Cited by 44
Omran, B. A., Tseng, B. S., & Baek, K.-H. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127656 · Cited by 44
Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux Pump Variants Exhibit Increased Virulence
Vaillancourt, M., Limsuwannarot, S. P., Bresee, C. J., Poopalarajah, R., & Jorth, P. A. (2021) · Antibiotics · doi:10.3390/antibiotics10101164 · Cited by 42
Polisetti, S., Baig, N. F., Morales-Soto, N., Shrout, J. D., & Bohn, P. W. (2017) · Applied Spectroscopy · doi:10.1177/0003702816654167 · Cited by 41
Mhade, S., & Kaushik, K. S. (2023) · ACS Omega · doi:10.1021/acsomega.2c07255 · Cited by 41
Žiemytė, M., Carda-Diéguez, M., Rodríguez-Díaz, J. C., Ventero, M. P., Mira, A., & Ferrer, M. D. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1994355 · Cited by 40
Mao, G., Song, Y., Bartlam, M. G., & Wang, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00879 · Cited by 39
Li, K., Yang, G., Debru, A. B., Li, P., Zong, L., Li, P., Xu, T., Wu, W., Jin, S., & Bao, Q. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01045 · Cited by 38
Brandenburg, K. S., Weaver, A. J., Qian, L., You, T., Chen, P., Karna, S. L. R., Fourcaudot, A. B., Sebastian, E. A., Abercrombie, J. J., Pineda, U., et al. (2019) · Journal of Burn Care & Research · doi:10.1093/jbcr/iry043 · Cited by 38
Pizzolato-Cezar, L. R., Spira, B., & de Miranda, M. T. M. (2023) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2023.100204 · Cited by 38
Kamer, A. M. A., El Maghraby, G. M., Shafik, M. M., & Al-Madboly, L. A. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03397-z · Cited by 38
Ngai, Y. T., Lau, D., Mittal, P., & Hoffmann, P. (2025) · Analytical Science Advances · doi:10.1002/ansa.70016 · Cited by 38
Feng, Q., Ahator, S. D., Zhou, T. H., Liu, Z., Lin, Q., Liu, Y., Huang, J., Zhou, J., & Zhang, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01226 · Cited by 37
Transcription of the alginate operon in Pseudomonas aeruginosa is regulated by c-di-GMP
Liang, Z., Rybtke, M., Kragh, K. N., Johnson, O., Schicketanz, M., Zhang, Y. E., Andersen, J. B., & Tolker-Nielsen, T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00675-22 · Cited by 36
De Soir, S., Parée, H., Kamarudin, N. H. N., Wagemans, J., Lavigne, R., Braem, A., Merabishvili, M., De Vos, D., Pirnay, J.-P., & Van Bambeke, F. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03219-23 · Cited by 36
Abouhagger, A., Celiešiūtė-Germanienė, R., Bakute, N., Stirke, A., & Melo, W. C. M. A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1419570 · Cited by 36
Biofilms can act as plasmid reserves in the absence of plasmid specific selection
Røder, H. L., Trivedi, U., Russel, J., Kragh, K. N., Herschend, J., Thalsø-Madsen, I., Tolker‐Nielsen, T., Bjarnsholt, T., Burmølle, M., & Madsen, J. S. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00249-w · Cited by 35
Long, M. B., Gilmour, A., Kehl, M., Tabor, D. E., Keller, A. E., Warrener, P., Gopalakrishnan, V., Rosengren, S., Crichton, M. L., McIntosh, E., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202308-1403oc · Cited by 35
A review of wastewater-based epidemiology for antimicrobial resistance surveillance
Clarke, L. M., O’Brien, J. W., Murray, A. K., Gaze, W. H., & Thomas, K. V. (2024) · Journal of Environmental Exposure Assessment · doi:10.20517/jeea.2023.29 · Cited by 35
Multidrug-resistant bacteria quorum-sensing inhibitors: A particular focus on Pseudomonas aeruginosa
Maiga, A., Ampomah-Wireko, M., Li, H., Fan, Z., Lin, Z., Zhen, H., Kpekura, S., & Wu, C. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117008 · Cited by 34
Wang, T., Zheng, Y., Dai, J., Zhou, J., Yu, R., & Zhang, C. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00546-21 · Cited by 33
Al-Momani, H., Aolymat, I., Ibrahim, L., Albalawi, H., Al Balawi, D., Albiss, B. A., Almasri, M., & Alghweiri, S. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03441-y · Cited by 33
Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations
Santamarina-Fernández, R., Fuentes-Valverde, V., Silva-Rodríguez, A., García, P., Moscoso, M., & Bou, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052012 · Cited by 33
Zhu, X., Oh, H.-S., Ng, Y. C. B., Tang, P. Y. P., Barraud, N., & Rice, S. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01832-17 · Cited by 31
Pseudomonas aeruginosa kills Staphylococcus aureus in a polyphosphate-dependent manner
Shah, R., Narh, J. K., Urlaub, M., Jankiewicz, O., Johnson, C., Livingston, B., & Dahl, J. (2024) · mSphere · doi:10.1128/msphere.00686-24 · Cited by 31
Dispersal of Epithelium-Associated Pseudomonas aeruginosa Biofilms
Zemke, A. C., D’Amico, E. J., Snell, E. C., Torres, A. M., Kasturiarachi, N. S., & Bomberger, J. M. (2020) · mSphere · doi:10.1128/msphere.00630-20 · Cited by 30
Nizer, W. S. D. C., Allison, K. N., Adams, M. E., Vargas, M. A., Ahmed, D., Beaulieu, C., Raju, D., Cassol, E., Howell, P. L., & Overhage, J. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00922-24 · Cited by 30
Cooley, R. B., O’Donnell, J. P., & Sondermann, H. (2016) · eLife · doi:10.7554/elife.21848 · Cited by 29
Fong, J. N. C., & Yildiz, F. H. (2015) · Microbial Biofilms · doi:10.1128/9781555817466.ch10 · Cited by 29
Gomes-Fernandes, M., Gómez, A.-C., Bravo, M., Huedo, P., Coves, X., Prat, C., Gibert, I., Lacoma, A., & Yero, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-07018-5 · Cited by 29
Eilers, K., Yam, J. K. H., Morton, R., Yong, A. M. H., Brizuela, J., Hadjicharalambous, C., Liu, X., Givskov, M., Rice, S. A., & Filloux, A. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.949597 · Cited by 29
Recent Advance in Small Molecules Targeting RhlR of Pseudomonas aeruginosa
Lim, T., Ham, S., Nam, S., Kim, M., Lee, K. Y., Park, H., & Byun, Y. (2022) · Antibiotics · doi:10.3390/antibiotics11020274 · Cited by 28
Manohar, P., Loh, B., Turner, D., Tamizhselvi, R., Mathankumar, M., Elangovan, N., Nachimuthu, R., & Leptihn, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1344962 · Cited by 28
Kim, H., Ham, S., Ryoo, H.-S., Kim, D.-H., Yun, E.-T., Park, H., & Park, J. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162180 · Cited by 26
Malcom, H. B., & Bowes, D. A. (2025) · Microorganisms · doi:10.3390/microorganisms13092073 · Cited by 26
Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly- l -Lysine
Guillon, A., Fouquenet, D., Morello, E., Henry, C., Georgeault, S., Si-Tahar, M., & Hervé, V. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00564-18 · Cited by 25
NO donors and NO delivery methods for controlling biofilms in chronic lung infections
Cai, Y.-M., Zhang, Y.-D., & Yang, L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11274-2 · Cited by 25
c-di-GMP and its Effects on Biofilm Formation and Dispersion: a Pseudomonas Aeruginosa Review
Ha, D.-G., & O'Toole, G. A. (2015) · Microbial Biofilms · doi:10.1128/9781555817466.ch15 · Cited by 24
Rath, A., Kieninger, B., Fritsch, J., Caplunik-Pratsch, A., Blaas, S., Ochmann, M., Pfeifer, M., Hartl, J., Holzmann, T., & Schneider-Brachert, W. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.01.009 · Cited by 23
Shen, Y., Wang, Y., Wang, J., Xie, P., Xie, C., Chen, Y., Banaei, N., Ren, K., & Cai, Z. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.031 · Cited by 23
Giallonardi, G., Letizia, M., Mellini, M., Frangipani, E., Halliday, N., Heeb, S., Cámara, M., Visca, P., Imperi, F., Leoni, L., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1183681 · Cited by 22
Toward Comprehensive Analysis of the 3D Chemistry of Pseudomonas aeruginosa Biofilms
Kotowska, A. M., Zhang, J., Carabelli, A., Watts, J., Aylott, J. W., Gilmore, I. S., Williams, P., Scurr, D. J., & Alexander, M. R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04443 · Cited by 22
Lin, L.-C., Tsai, Y.-C., & Lin, N.-T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115337 · Cited by 22
Biofilms Exposed: Innovative Imaging and Therapeutic Platforms for Persistent Infections
Haval, M., Unakal, C., Ghagane, S. C., Pandit, B. R., Daniel, E., Siewdass, P., Ekimeri, K., Rajamanickam, V., Justiz-Vaillant, A., Lootawan, K.-A. A., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14090865 · Cited by 22
Pseudomonas aeruginosa biofilm dispersion by the mouse antimicrobial peptide CRAMP
Zhang, Y., Cheng, P., Wang, S., Li, X., Peng, L., Fang, R., Xiong, J., Li, H., Mei, C., Gao, J., et al. (2022) · Veterinary Research · doi:10.1186/s13567-022-01097-y · Cited by 21
Engineering quorum quenching acylases with improved kinetic and biochemical properties
Sompiyachoke, K., & Elias, M. H. (2024) · Protein Science · doi:10.1002/pro.4954 · Cited by 21
Quorum sensing regulation of Psl polysaccharide production by Pseudomonas aeruginosa
Carey, J. N., Lamont, S., Wozniak, D. J., Dandekar, A. A., & Parsek, M. R. (2024) · Journal of Bacteriology · doi:10.1128/jb.00312-24 · Cited by 21
Keim, K. C., Bhattacharya, M., Crosby, H. A., Jenul, C., Mills, K. B., Schurr, M. J., & Horswill, A. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621402 · Cited by 20
Phenazine oxidation by a distal electrode modulates biofilm morphogenesis
Cornell, W. C., Zhang, Y., Bendebury, A., Hartel, A. J. W., Shepard, K. L., & Dietrich, L. E. P. (2020) · Biofilm · doi:10.1016/j.bioflm.2020.100025 · Cited by 19
Haji, S. H., Ganjo, A. R., Faraj, T. A., Fatah, M. H., & Smail, S. B. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03530-y · Cited by 19
Drinking water plumbing systems are a hot spot for antimicrobial-resistant pathogens
Hayward, C., Ross, K. E., Brown, M. H., Bentham, R., Hinds, J., & Whiley, H. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.02.018 · Cited by 19
Dela Ahator, S., Liu, Y., Wang, J., & Zhang, L.-H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.987656 · Cited by 18
Mangiaterra, G., Cedraro, N., Vaiasicca, S., Citterio, B., Galeazzi, R., Laudadio, E., Mobbili, G., Minnelli, C., Bizzaro, D., & Biavasco, F. (2020) · Antibiotics · doi:10.3390/antibiotics9070399 · Cited by 17
Dangla-Pélissier, G., Roux, N., Schmidt, V., Chambonnier, G., Ba, M., Sebban‐Kreuzer, C., de Bentzmann, S., Giraud, C., & Bordi, C. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab827 · Cited by 17
Pleguezuelos-Manzano, C., Beenker, W. A. G., van Son, G. J. F., Begthel, H., Amatngalim, G. D., Beekman, J. M., Clevers, H., & den Hertog, J. (2025) · Scientific Reports · doi:10.1038/s41598-024-82500-w · Cited by 17
Qu, J., Cai, Z., Duan, X., Zhang, H., Cheng, H., Han, S., Yu, K., Jiang, Z., Zhang, Y., Liu, Y., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00748-z · Cited by 16
Devine, B. C., Dogan, A. B., & Sobol, W. M. (2025) · Bioengineering · doi:10.3390/bioengineering12050441 · Cited by 16
Debast, S. B., van den Bos-Kromhout, M. I., de Vries-van Rossum, S. V., Abma-Blatter, S. E. M., Notermans, D. W., Kluytmans, J. A. J. W., Immeker, B., Zuur, J. K., Hijmering, M. L., Bergwerff, A. A., et al. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.05.024 · Cited by 16
Local control: A hub-based model for the c-di-GMP network
Vasenina, A., Fu, Y., O'Toole, G. A., & Mucha, P. J. (2024) · mSphere · doi:10.1128/msphere.00178-24 · Cited by 13
Hultqvist, L. D., Andersen, J. B., Nilsson, C. M., Jansen, C. U., Rybtke, M., Jakobsen, T. H., Nielsen, T. E., Qvortrup, K., Moser, C., Graz, M., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01481-23 · Cited by 13
Martino, R. A., Volke, D. C., Tenaglia, A. H., Tribelli, P. M., Nikel, P. I., & Smania, A. M. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70137 · Cited by 13
Flores-Maldonado, O. E., Lezcano-Domínguez, C. I., Dávila-Aviña, J., González, G. M., & Ríos-López, A. L. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106830 · Cited by 12
Tchadi, B. V., Derringer, J. J., Detweiler, A. K., & Taylor, I. R. (2025) · Journal of Bacteriology · doi:10.1128/jb.00516-24 · Cited by 12
FlhF affects the subcellular clustering of WspR through HsbR in Pseudomonas aeruginosa
Guan, C., Huang, Y., Zhou, Y., Han, Y., Liu, S., Liu, S., Kong, W., Wang, T., & Zhang, Y. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.01548-23 · Cited by 11
Diriba, K., Subedi, D., Kumar, N., & Willcox, M. D. P. (2025) · Antibiotics · doi:10.3390/antibiotics14070629 · Cited by 11
Fisher, O. J., Wang, Y., & Ahmed, A. (2025) · Water Research · doi:10.1016/j.watres.2025.124491 · Cited by 11
Lee, A. J., Doing, G., Neff, S. L., Reiter, T., Hogan, D. A., & Greene, C. S. (2023) · mSystems · doi:10.1128/msystems.00342-22 · Cited by 10
Cordery, C., Craddock, J., Malý, M., Basavaraja, K., Webb, J. S., Walsh, M. A., & Tews, I. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00113c · Cited by 10
Jain, A., Dabburu, G. R., Samanta, B., Singhal, N., & Kumar, M. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf190 · Cited by 10
Su, T., He, J., Li, N., Liu, S., Xu, S., & Gu, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00760 · Cited by 9
Cao, T., Weaver, A. A., Baek, S., Jia, J., Shrout, J. D., & Bohn, P. W. (2021) · The Journal of Chemical Physics · doi:10.1063/5.0052785 · Cited by 8
Mangiaterra, G., Cedraro, N., Vaiasicca, S., Citterio, B., Frangipani, E., Biavasco, F., & Vignaroli, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411618 · Cited by 8
Investigating Pseudomonas aeruginosa Gene Function During Pathogenesis Using Mobile-CRISPRi
Yu, M. A., Banta, A. B., Ward, R. D., Prasad, N. K., Kwon, M. S., Rosenberg, O. S., & Peters, J. M. (2024) · Methods in Molecular Biology · doi:10.1007/978-1-0716-3473-8_2 · Cited by 8
Advances in electrochemical detection of bacterial biofilm metabolites
Haghighian, N., & Kataky, R. (2024) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2024.101486 · Cited by 8
Matrix-assisted laser desorption/ionization mass spectrometry imaging for quorum sensing
Kuik, C., van Hoogstraten, S. W. G., Arts, J. J. C., Honing, M., & Cillero-Pastor, B. (2024) · AMB Express · doi:10.1186/s13568-024-01703-6 · Cited by 8
Heise, B., Zorin, I., Duswald, K., Karl, V., Brouczek, D., Eichelseder, J., & Schwentenwein, M. (2024) · Frontiers in Materials · doi:10.3389/fmats.2024.1441812 · Cited by 8
Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
Dallal Bashi, Y. H., Mairs, R., Murtadha, R., & Kett, V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010111 · Cited by 8
Harnessing machine learning to predict antibiotic susceptibility in Pseudomonas aeruginosa biofilms
Vergauwe, F., De Waele, G., Sass, A., Highmore, C., Hanrahan, N., Cook, Y., Lichtenberg, M., Cnockaert, M., Vandamme, P., Mahajan, S., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00833-4 · Cited by 8
Pseudomonas Aeruginosa Antibiotic Efflux Pump Variants Exhibit Increased Virulence
Vaillancourt, M., Limsuwannarot, S. P., Bresee, C., Poopalarajah, R., & Jorth, P. (2021) · doi:10.20944/preprints202109.0032.v1 · Cited by 8
SadB, a mediator of AmrZ proteolysis and biofilm development in Pseudomonas aeruginosa
Ben-David, Y., Sporny, M., Brochin, Y., Piscon, B., Roth, S., Zander, I., Nisani, M., Shoshani, S., Yaron, O., Karako-Lampert, S., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00710-0 · Cited by 6
Querin, B., Danjean, M., Jolivet, S., Couturier, J., Oubbéa, S., Jouans, C., Lazare, C., Montagne, T., Chamming’s, A., Luce, S., et al. (2025) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-025-01599-2 · Cited by 6
(2012) · Current Issues in Molecular Biology · doi:10.21775/cimb.014.047 · Cited by 5
Pleguezuelos-Manzano, C., Beenker, W. A. G., van Son, G. J. F., Begthel, H., Amatngalim, G. D., Beekman, J. M., Clevers, H., & den Hertog, J. (2023) · doi:10.1101/2023.03.11.532178 · Cited by 5
van der Ploeg, K., de Vogel, C. P., Klaassen, C. H. W., Luider, T. M., Zeneyedpour, L., Slingerland, B., Vos, M. D., Bruno, M. J., Bexkens, M. L., & Severin, J. A. (2025) · Biofilm · doi:10.1016/j.bioflm.2025.100310 · Cited by 4
Román‐Rodríguez, F., Tyagi, N., Kim, J., Parker, D., & Boyd, J. M. (2025) · Journal of Bacteriology · doi:10.1128/jb.00101-25 · Cited by 4
Nguyen, N. T., Kurisu, F., Furumai, H., & Kasuga, I. (2023) · Journal of Water and Environment Technology · doi:10.2965/jwet.22-063 · Cited by 3
Qi, Z., & Liu, C. (2024) · Journal of Environmental Chemical Engineering · doi:10.1016/j.jece.2024.113514 · Cited by 3
Weaver, A. A., & Shrout, J. D. (2025) · Journal of Bacteriology · doi:10.1128/jb.00402-24 · Cited by 3
Raya, J., Montagut, E.-J., & Marco, M.-P. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1634997 · Cited by 3
Time-resolved dual transcriptomics of Pseudomonas aeruginosa biofilm formation in cystic fibrosis
Asensio, N. C., Rendón, J. M., González López, J. J., Tizzano, S. G., Martín Gómez, M. T., & Burgas, M. T. (2025) · Biofilm · doi:10.1016/j.bioflm.2025.100301 · Cited by 3
Demidov, V. V., Jackson, O. P., Demidova, N., Gunn, J. R., Gitajn, I. L., & Elliott, J. T. (2025) · Journal of Biomedical Optics · doi:10.1117/1.jbo.30.s3.s34111 · Cited by 3
Roman-Rodriguez, F., Kim, J., Parker, D., & Boyd, J. M. (2025) · doi:10.1101/2025.03.12.642861 · Cited by 2
SadB acts as a master regulator modulating Pseudomonas aeruginosa pathogenicity
Papangeli, M., Luckett, J., Heeb, S., Alexander, M. R., Williams, P., & Dubern, J.-F. (2025) · doi:10.1101/2025.09.11.675511 · Cited by 1
(2021) · doi:10.22038/ijbms.2021.52217.11813
Research works printed but not linked: 1
- Jia, J. (2021). Spatiotemporal Mapping of Quinolone and Phenazine Secretion in Pseudomonas aeruginosa Biofilms by Confocal Raman Imaging. [Ph.D. Thesis, University of Notre Dame].
Cited by
Molecular Mechanisms Underlying the Pathogenicity of Pseudomonas aeruginosa
Krūmiņa, A., Reinis, A., Jeske, A., Zeltiņa, I., & Vīksna, L. (2026) · Medicina · doi:10.3390/medicina62030462 · Cited by 8
Murugesan, T., Pugazhendhi, S., Muthukumar, M., Arumugam, K., & Sehgal, R. (2026) · The Microbe · doi:10.1016/j.microb.2026.100753 · Cited by 4
Biofilm formation: Regulatory mechanisms and therapeutic strategies
Ma, W., Zhang, J., Cheng, Y., Zhai, M., Zhou, J., & Qu, J. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128597 · Cited by 4
Engineered Phage Modulates Quorum Sensing and Biofilm Formation in Pseudomonas aeruginosa
Franco, D., Papasergi, S., Mediati, F., Guglielmino, S. P. P., & Plano, L. M. D. (2026) · Microorganisms · doi:10.3390/microorganisms14051028 · Cited by 2
Mubeen, M., Mumtaz, B., Shafiq, M. U., Thant, P. S., Mahmood, T., Mushtaq, M. A., Siddiqui, S., Zulfiqar, F., & Moosa, A. (2026) · Physiological and Molecular Plant Pathology · doi:10.1016/j.pmpp.2026.103363 · Cited by 2
Metadata
- Authors
- Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., & Abu-Okail, A.
- Affiliations
- Qassim University (SA)
- University of Tabuk (SA)
- King Khalid University (SA)
- Family Medicine Department, King Fahad Armed Hospital, Jeddah 23311, Saudi Arabia
- Home Health Care Department, King Fahad Armed Forces Hospital, Jeddah 23311, Saudi Arabia
- Prince Sultan Military College of Health Sciences (SA)
- Corresponding author
- Elbehiry, Ayman
- ORCID
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2026-01-04
- Volume
- 14
- Issue
- 1
- Pages
- 109
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC12844471
- OpenAlex
- W7118168642
- Semantic Scholar
- e7f25d8a025e648f1a1aed31f52cfb4aac2076b4
- Cited by
- 34
- References
- 291
- Citations by year
- 2026: 34
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Qassim University (QU- APC-2026)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Keywords
- Pseudomonas aeruginosa, biofilm, quorum sensing, c-di-GMP signaling, biofilm matrix, efflux pumps, MexAB-OprM, MexEF-OprN, persister cells, viable but non-culturable bacteria, antibiotic tolerance, minimum biofilm eradication concentration, QS inhibitors, nitric oxide donors, bacteriophages, host-directed therapy, biofilm dispersal, One Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.